User Stats

Rank: 1500
Karma Score: 12
Joined: May 16, 2023
Submitted Stories: 6
Published Stories: 0
Comments: 0
Votes: 6
Group Name
Membership unavailable


No Following!


No Follower!


Net Worth Hive

Welcome to Net Worth Hive. We are a digital platform, that will provide you with every detail of the financial statement of your favorite person.

Lorlatinib 100 mg (Lorbrexen) - An Effective Treatment for NSCLC

Lorlatinib 100 mg (Lorbrexen) is a highly effective targeted therapy for patients with ALK-positive non-small cell lung cancer. Learn more about these meds. Non-small cell lung cancer (NSCLC) is the most common type, accounting for 85% of all cases. Among patients with NSCLC, those diagnosed with ALK-positive tumors have a specific mutation in the anaplastic lymphoma kinase (ALK) gene. Lorlatinib, a medication designed to inhibit cancer cell growth and spread, can target this mutation. In this article, we will explore the benefits, side effects, and dosage of Lorlatinib 100 mg, effective treatment for ALK-positive NSCLC.

ibrucent ibrutinib Imbruvica 140 mg

Ibruxen 140 mg Ibrutinib is a cancer medicine. It works by blocking an abnormal protein that signals cancer cells to multiply. it helps to stop cancer cells. Generic Name: Ibrutinib Manufacturer: Everest Pharma Capsule: 12’s Strip / 90’s Pot Originator: Imbruvica by Pfizer Contact For Order: WhatsApp & WeChat: +8801886229488 Email: